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The Human Metllothionein Gene Family:
Structure and Expression
by Michael Karin* and Robert 1. Richardst
Metallothioneins (MTs) are encoded by a multigene family in man. We have isolated
those genesand analyzedthe structure ofsome ofthem. TheMT-IIvariantisencodedby a
single functional gene: MT-IIA. The MT-IIB geneis aprocessed pseudogene derived from a
reverse transcript of MT-II mRNA. On the other hand, the MT-I class of variants are
encodedbyalargenumberofgenes, arrangedintandem. The MT-IIAandthe MT-IAgenes
show a differential response to glucocorticoid hormones and heavy metals, yet they are
both expressed in primary human fibroblasts and in HeLa cells. Expression of both of
those genes, in high level after transfer on bovine papilloma virus vectors, leads to
increased resistance ofthe host cells to cadmium-induced toxicity.
Introduction
Metallothioneins (MTs) are a group oflow mo-
lecular weight heavy metal binding proteins,
unique intheirhigh cysteine content. MTs specifi-
cally bind heavy metals such as zinc, cadmium,
copper and mercury (1). MTs were discovered in
1957 by Margoshes and Valee (2), who have iso-
lated a Cd2+ and Zn2+ binding protein from horse
kidney. In 1966 Pulido et al. (3) isolated MTsfrom
human liver. Since then, MTs were isolated and
characterized from a larger number ofspecies.
In 1964, Piscator (4) foundthat MT was present
inelevated levels in the liverofrabbits exposed to
cadmium. He postulated that the biosynthesis of
the protein is induced by Cd2+ and that MT acts
as a detoxifying agent by binding of Cd2+. The
induction of MTs after administration ofvarious
heavy metal ions was demonstrated in many dif-
ferent animal species and in cultured cells (1). In
1979 Karin and Herschman (5) demonstrated
that the synthesis of MTs in cultured cells is
induced not only by heavy metal ions, but also by
glucocorticoid hormones. This finding strongly
supports the proposal that MTs have an impor-
tant role in regulation of trace element metabo-
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lism and, that glucocorticoids by elevating the
rate of synthesis of MTs, control Cd2+ and Zn2+
homeostasis.
In this paper, we will review our studies con-
cerning the structure and expression ofthe genes
encoding MTs in man.
Structure of the Human MT Gene
Family
Tb define the structure and understand the reg-
ulation ofhuman MT genes, it was necessary to
obtain cDNA clones ofhuman MT mRNA. A good
source ofhuman MT mRNA are HeLa cells which
were found to express high levels of MTs in re-
sponse to Cd2+ (6). We have constructed a cDNA
library from Cd2+ induced HeLa cells and by
differential hybridization isolated a number of
cDNA clones which preferentially hybridized to
mRNA from Cd2+ induced cells. Using a mouse
MT-I cDNA clone (7), we have identified among
those clones several cDNA clones of human MT
mRNA. The full nucleotide sequence ofone ofthe
clones was determined and it was found to be a
nearly full-length cDNA clone of human MT-fl
mRNA (8). The coding region of that cDNA was
used as a hybridization probe for detection of
human MT genes in digests of human genomic
DNA and their isolation from a genomic DNA
library. To our surprise, we foundhuman DNA to
contain at least 12 different EcoRI fragmentsKARIN AND RICHARDS
hybridizing to the coding region probe. Also the
frequency of bacteriophage clones hybridizing to
the same probe was about 11 per genome equiva-
lent, suggesting that in man MTs are encoded by
a multigene family (9). Tb identify those genes
encodingthe MT-IIform (10) we have screened all
of the genomic clones isolated, for hybridization
to the 5' and 3' untranslated regions of MT-
IIcDNA. Only three of the genomic clones were
positive by these criteria: one of them contained
the functional MT-IIA gene and two ofthem were
overlapping clones containing a processed
pseudogene named MT-IIB (9). We are fairly confi-
dent that the MT-IIA gene is the only functional
human MT-II gene. Complete nucleotide sequence
determination has demonstrated the presence of
an open reading frame, interrupted by two in-
trons, encoding the MT-II form (9).
The MT-IIB is a nonfunctional processed gene
derived from MT-II mRNA, by its conversion into
a full length cDNA by a yet unidentified enzy-
matic activity in the germ line, and the integra-
tion of that cDNA into a staggered break in the
genomic DNA. Although the MT-IIB gene encodes
a potentially functional MT, it is not expressed
(9), due to the absence of a promoter element
(M. Karin, unpublished).
More recently we have begun the characteriza-
tion ofgenomic clones containing MT-Ilike genes.
The MT-I genes are tightly clustered and, so far,
we have identified seven such genes, tandemly
iterated within a 30 Kb region. Not all of those
genes are necessarily functional and, so far, we
have found two ofthem to be pseudogenes due to
the presence of frameshift and nonsense muta-
tions resulting in the introduction of premature
termination codons (R. Richards and M. Karin,
unpublished). However, one ofthe genes, named
MT-IA was found to be a functional gene by using
an assay described in the next section.
Increased Resistance to Cd2+
of Cells Expressing High Levels
of MT
Bovine papilloma virus (BPV) is a DNA tumor
virus with several unique properties making it
useful as a mammalian plasmid vector. First, this
virus does not integrate into the cellular genome
and instead it maintains itself as a free replicat-
ing nuclear plasmid. Second, it does not lead to
the lysis ofthe cells in which it replicates (11). We
have used these properties of the virus and li-
gated a fragment ofit to the cloned human MT-IIA
gene to generate the vector pMTII-BPV. Cells
transformed with this vector express high levels
ofhuman MT-II mRNA and protein. That expres-
sion is regulated by the concentration of Cd2+ in
the growthmedium, eventhoughthehuman gene
is present in an episomal state. Moreover, due to
the high level of expression ofhuman MT-II, the
transformed cells become highly resistant to
Cd2+. In fact, while the relative plating efficiency
ofthe parental cells drops to 10% at 1 p M Cd2+,
the relative plating efficiency of cells containing
pMTII-BPV drops to 10% only at 25 ji M Cd2+
(12). Actually, the cells transformed with pMTII-
BPV are Zn2+ dependent due to the high level of
synthesis ofhuman MT-II (about 12% ofthe solu-
ble protein).
In the absense of any recognized enzymatic
activity, we consider the increased Cd2+ resist-
ance ofcells harboring BPV-MT plasmids, a crite-
ria for the functionality of a MT gene and the
protein itencodes. This assayhasturned outtobe
quite useful in the characterization ofhuman MT
genes. For example, we have recently determined
the full nucleotide sequence of the MT-IA gene
(R. Richards and M. Karin, in preparation) and
found the amino acid sequence of the encoded
protein to deviate from the published sequence of
human MT-I's (13). We were concerned whether
this gene is functional or not and therefore have
inserted it into the BPV vector. Mouse cells trans-
formed with this vector (pMTIA-BPV) were found
to be Cd2+-resistant, indicating that the MT-IA
gene is functional (R. Richards and M. Karin, in
preparation). This illustrates the usefulness of
the BPV vector system to the functional analysis
of a multigene family. Since the MT-BPV trans-
formed cells produce very high levels ofMT, they
can serve as a convenient source for the isolation
of large amounts of relatively homogenous MT
variants for biochemical studies.
Expression of Human MT Genes
Addition ofCd2+, Zn2+ and Cu2+ to the culture
medium of human HeLa or primary fibroblast
cells leads to rapid induction of MT mRNA (14
and Richards and Karin, in preparation). The
same mRNA's species are also induced by the
addition of glucocorticoid hormones (14 and M.
Karin, unpublished). Both heavy metal ions and
hormonal inductions are consideredtobeprimary
induction responses, since they lead to an in-
crease in mRNA levels even in the absence of
concurrent protein synthesis (15). Palmiter and
co-workershave demonstratedthat in mouse cells
both classes of inducers act by increasing the
transcription rate of the MT-I gene (16,17). Re-
cently, we found that the human MT-IA and MT-
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IIA genesresponddifferently to different inducers,
indicatingpossiblefunctional differences between
those genes (R. Richards and M. Karin, in prepa-
ration).
The kinetics of induction of MT mRNA by a
typical heavy metal ion inducer such as Zn2+ and
dexamethasone, a synthetic glucocorticoid, are
different. Both inducers lead to rapid induction of
MT mRNA, but while the response to metal is
biphasic and the level ofthe mRNA declines after
prolonged exposure, the response to the hormone
is persistent and once a new elevated steady state
level of MT mRNA is achieved, it is maintained
as long as the hormone is present (14,18). The
transient induction observed with Zn2+ is not due
to a cytotoxic effect ofthe metal or to disappear-
ance ofthe inducer due to MT induction. Another
difference between the two responses is in the
way they are affected by inhibition of protein
synthesis. While hormonal induction of MT
mRNA is only slightly elevated in the absence of
protein synthesis, the induction by Zn2+ is
augmented about threefold. Also, the basal level
ofMT mRNA is increased threefold by inhibition
of protein synthesis (15). Mayo and Palmiter
found that the cycloheximide effect is exerted at
the level oftranscription, bycomparingtranscrip-
tion rates ofthe mouse MT-I gene in the presence
and absence ofcycloheximide (19).
These observations led us to suggest that (a)
heavy metal ions and glucocorticoid hormones
increase the transcription rates of MT genes by
different mechanisms and (b) heavy metal induc-
tion is mediated through the removal ofa repres-
sor of MT gene expression. However, as a conse-
quence of metal induction the level of the
repressor is increased causing a transient induc-
tion response. Inhibition of the synthesis of this
putative repressor by cycloheximide causes a
large augmentation of the induction response to
metal ions. In our simplest working hypothesis
the repressor is apothionein (see Fig. 1), which
explains the specificity ofthe induction response,
since only metal ions that bind to the apoprotein
can lead to induction. This induction is due to the
conversion of apotheionein, the active repressor
form, to metallothionein, the inactive repressor
form. After a while, the level ofMT in the cell is
increased, but so does the level ofthe apoprotein,
the putative repressor, leading to a decrease in
the transcription rate of the MT genes, and re-
sulting in a transient induction response. Induc-
tionby glucocorticoids bypasses thispathway and
leads to persistent activation ofthe genes, as long
as, the hormone receptor complex is bound to
DNA (18).
A MODEL FOR METALLOTHIONEIN
GENE ACTIVATION BY HEAVY METALS
PROMOTER REGION
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FIGURE 1. A model for metallothionein gene activation by
heavy metals.
More recently we have compared the expres-
sion ofthe MT-IIA and the MT-IA genes in human
cells. We find that while the MT-IIA gene is in-
duced to the same extent by Cd2+, Zn2+, Cu2+ and
dexamethasone, the MT-IA gene is only fully in-
duced by Cd2+. These results suggest that the
various MT genes are regulated differently from
each, most likely due to the different functions
they serve.
Localization of the Regulatory
Elements of Human MT Genes
As indicated, both the human MT-IA and the
MT-IIA genes are still inducible by heavy metal
ions after transfer into rodent cells on BPV de-
rived sectors (12). While being appropriate for
studying metal induction, this sytem is not suit-
able for studying the hormonal regulation of
cloned MT genes, since the episomal state pre-
cludes glucocorticoid induction. On the other
hand, cotransfer (with the Herpes simplex virus
thymidine kinase gene) of the human MT-IIA
gene, into rat fibroblasts leading to stable inte-
gration into the host genome, results in retention
of full responsiveness to both glucocorticoid hor-
mones and heavy metal ions.
To test whether the regulatory DNA elements
controlling MT-IIA gene expression are found
within the 800 bp 5' flanking region ofthe cloned
fragment used in the transfection experiments
mentioned above, wehave fusedthis region tothe
structural portion of the Herpes simplex virus
(HSV) thymidine kinase (TK) gene. The tran-
scription of TK mRNA from this fusion gene
(hMTK) is under the control ofthe human MT-IIA
gene promoter. The hMTK fusion gene was intro-
ducedintoTK- ratfibroblastsbytransfection and
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selection for the TK+ phenotype. The expression
ofTK mRNA in those cells was found to be both
heavy metal and hormone inducible. These
results indicate that the important regulatory
elements for both heavy metal and glucocorticoid
inductions are found within 800 bp of the 5'
flanking region ofthe human MT-IIA gene. Mea-
suringthe rate ofsynthesis ofMTK mRNA under
different induction conditions demonstrated tran-
scriptional control by both Cd2+ and dexametha-
sone (20). Morerecentlybyperforming sequential
deletions of5' flanking nucleotides ofthe hMTK
gene we found that only 300 bp are sufficient for
maintenance of both hormone and metal induc-
tion (M. Karin et al., unpublished).
Conclusions
By applying recombinant DNA technology to
study of structure and function of MT genes in
man we were able to demonstrate that: (a) this
group of proteins is encoded by a large gene
family, (b) different MT genes vary in their re-
sponse to various inducers, (c) overexpression of
MT genes leads to protection of cultured cells
against the toxic effect ofCd2+ and (d) the regula-
tory DNA elements controlling the expression of
the human MT-IIA gene are located within 300 bp
of 5' flanking DNA whose primary structure is
known.
The differences in the response of the MT-IIA
and MT-IA gene to various inducers suggest that
the two genes have different functions. Since the
MT-IIA gene is the one which is highly inducible
by glucocorticoids and zinc, we believe this gene
serves a homeostatic role. The modulation of
MT-II expression by zinc, copper and glucocorti-
coids help to maintain zinc and copper homeosta-
sis. During periods ofhigh availability, zinc and
copper stimulate the transcription of the MT-IIA
gene, leading to increased production of MT-II,
mostly inthe liver, which results inthe storage of
the excess amounts of those essential trace
metals. Glucocorticoids, by increasingthe expres-
sion ofMT-II, cause mobilization ofzinc andprob-
ably copper fromthe circulation intothe liver and
other organs, leading eventually to hypozince-
mia.
On the other hand, the expression ofthe MT-IA
gene, and possibly of the other MT-I genes, as
well, is not highly stimulated by glucocorticoids
and zinc or copper. Only cadmium seems to be a
potent inducer of those genes. Therefore, we be-
lieve the MT-I genes serve a protective role. This
hypothesis is supported by the multiplicity of
MT-I genes in most mammals except rodents.
Primates have at least four functional MT-I
genes (J. Kagi and M. Kimura, personal com-
munications). If all of those genes are activated
by Cd2+, this would constitute an efficient protec-
tive response, due to a massive increase in the
synthesis MT-I resulting in the chelating of the
toxic Cd2+ ions.
Inthe futurewe planto further characterize all
the different MT genes and study their organiza-
tion within the genome. We hope to be able to
understand the genetic mechanism which has led
to the generation ofmultiple MT-I genes in man.
We alsoplan to investigate whether there are any
tissue-specific variations in the expression ofthe
different human MT genes. Finally we hope to be
able to reconstitute an in vitro induction system,
consisting of cloned MT genes, a few regulatory
proteins and RNApolymerase-II. By using such a
system it should be possible to determine how
heavy metals control gene expression.
Work in Dr. Karin's laboratory is supported by grant No. R-
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